- Home
- ANVS vs CLEU Comparison
ANVS vs CLEU Comparison
Compare ANVS & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- CLEU
- Stock Information
- Founded
- ANVS 2008
- CLEU 2011
- Country
- ANVS United States
- CLEU China
- Employees
- ANVS N/A
- CLEU N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- CLEU Other Consumer Services
- Sector
- ANVS Health Care
- CLEU Real Estate
- Exchange
- ANVS Nasdaq
- CLEU Nasdaq
- Market Cap
- ANVS 24.2M
- CLEU 20.0M
- IPO Year
- ANVS 2020
- CLEU 2020
- Fundamental
- Price
- ANVS $1.53
- CLEU $1.86
- Analyst Decision
- ANVS Strong Buy
- CLEU
- Analyst Count
- ANVS 4
- CLEU 0
- Target Price
- ANVS $40.67
- CLEU N/A
- AVG Volume (30 Days)
- ANVS 460.8K
- CLEU 32.6K
- Earning Date
- ANVS 05-20-2025
- CLEU 01-01-0001
- Dividend Yield
- ANVS N/A
- CLEU N/A
- EPS Growth
- ANVS N/A
- CLEU N/A
- EPS
- ANVS N/A
- CLEU N/A
- Revenue
- ANVS N/A
- CLEU $2,413,409.00
- Revenue This Year
- ANVS N/A
- CLEU N/A
- Revenue Next Year
- ANVS N/A
- CLEU N/A
- P/E Ratio
- ANVS N/A
- CLEU N/A
- Revenue Growth
- ANVS N/A
- CLEU N/A
- 52 Week Low
- ANVS $1.11
- CLEU $0.05
- 52 Week High
- ANVS $17.88
- CLEU $7.90
- Technical
- Relative Strength Index (RSI)
- ANVS 49.17
- CLEU 50.66
- Support Level
- ANVS $1.42
- CLEU $1.83
- Resistance Level
- ANVS $1.75
- CLEU $1.95
- Average True Range (ATR)
- ANVS 0.16
- CLEU 0.13
- MACD
- ANVS 0.03
- CLEU 0.00
- Stochastic Oscillator
- ANVS 43.59
- CLEU 56.82
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.